These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9384674)

  • 1. Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemias.
    Kurzrock R; Wetzler M; Estrov Z; Talpaz M
    Cytokines Mol Ther; 1995 Sep; 1(3):177-84. PubMed ID: 9384674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia.
    Estrov Z; Kurzrock R; Talpaz M
    Leuk Lymphoma; 1993 Aug; 10(6):407-18. PubMed ID: 8401177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine networks: do we understand them well enough to facilitate clinical benefits?
    Feldmann M
    Eur Cytokine Netw; 1991; 2(1):5-9. PubMed ID: 1831391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia.
    Barak V; Nisman B; Polliack A; Vannier E; Dinarello CA
    Eur Cytokine Netw; 1998 Mar; 9(1):33-9. PubMed ID: 9613675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interleukin-1 beta converting enzyme (ICE) in leukemia.
    Estrov Z; Talpaz M
    Cytokines Mol Ther; 1996 Mar; 2(1):1-11. PubMed ID: 9384684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.
    Dinarello CA; Thompson RC
    Immunol Today; 1991 Nov; 12(11):404-10. PubMed ID: 1838480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.
    Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F
    Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of interleukin 1 in infection and sepsis].
    Beuscher HU; Rausch UP; Röllinghoff M
    Immun Infekt; 1992 Aug; 20(4):128-33. PubMed ID: 1398733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility.
    Merhi-Soussi F; Berti M; Wehrle-Haller B; Gabay C
    Cytokine; 2005 Nov; 32(3-4):163-70. PubMed ID: 16246569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS.
    Beaupre DM; Talpaz M; Marini FC; Cristiano RJ; Roth JA; Estrov Z; Albitar M; Freedman MH; Kurzrock R
    Cancer Res; 1999 Jun; 59(12):2971-80. PubMed ID: 10383163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological modulation of IL-1 activity: role and development of its natural inhibitor IL-1Ra].
    Dayer JM
    Reumatismo; 2004; 56(1 Suppl 1):3-8. PubMed ID: 15201935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
    Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
    Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interleukin-1 family.
    Roux-Lombard P
    Eur Cytokine Netw; 1998 Dec; 9(4):565-76. PubMed ID: 9889400
    [No Abstract]   [Full Text] [Related]  

  • 14. Proposed guidelines for the clinical evaluation of interleukin-1 inhibitors in the treatment of rheumatoid arthritis.
    Dougados M
    Eur Cytokine Netw; 1990; 1(4):235-7. PubMed ID: 2151768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
    Dayer JM
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii3-10. PubMed ID: 12817089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological properties and clinical importance of interleukin 1].
    Robak T
    Postepy Hig Med Dosw; 1995; 49(2):263-85. PubMed ID: 8657631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.
    Carlson NG; Wieggel WA; Chen J; Bacchi A; Rogers SW; Gahring LC
    J Immunol; 1999 Oct; 163(7):3963-8. PubMed ID: 10490998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
    Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
    Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-I antagonists.
    Dower SK; Fanslow W; Jacobs C; Waugh S; Sims JE; Widmer MB
    Ther Immunol; 1994 Apr; 1(2):113-22. PubMed ID: 7584483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.